Bromhexine
- Level
- Commodity
- Parent
- 51162700
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51162704This classification denotes an expectorant with the molecular formula C14H20Br2N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) Q1J152VB1P, chemically known as 3,5-dibromo-nalpha-cyclohexyl-nalpha-methyltoluene-alpha-2-diamine but more generally known as bromhexine, which bears US NIH Compound Identifier 2442. Bromhexine most often comes in base, chloride, and hydrochloride forms. European Medicines Agency schedules Bromhexine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05914MIG. World Health Organization schedules bromhexine in its Anatomical Therapeutic Chemical (ATC) Classification. BROMHEXINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule bromhexine under HS 29215990 and SITC 51455. As of Q4 2014, BROMHEXINE remains US FDA's Preferred Term for this commodity. SMILES: BRC1C(N)C(CN(C2CCCCC2)C)CC(BR)C1.
Same parent
Under 51162700 · 48Activities that produce or sell this
KBLI · 9Inherited from family 51160000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.